At this year’s ABRF Annual Meeting (23–26 March; NV, USA), biotech companies had the opportunity to showcase their technology ...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...

Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...

Find the latest IO Biotech news from Fast company. See related business and technology articles, photos, slideshows and videos.

Researchers will analyze tumor samples from more than 1,000 of the longest survivors with those cancer types for DNA, protein, microbial, and molecular biomarkers using 10x Genomics' Visium HD ...

2 Reasons to Sell TXG and 1 Stock to Buy Instead What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many shareholders. This was ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

The project, titled ‘Corsa’ promises a 10x speed boost for developers, along with a ‘substantial’ reduction in memory usage. Anders Hejlsberg, the lead architect of TypeScript, and a technical fellow ...